Across TCGA patient cohorts, OR2G6 mutation is significantly associated with the total protein of many other genes, with 19 significant associations in total. LUSC shows the largest number of these associations.

The most reproducible OR2G6-associated genes across cancer lineages are PI3K-p85, CD49b, and XRCC1. Each is linked with OR2G6 in more than 1 cancer types. Because this analysis shows association rather than direction, both OR2G6-to-partner and partner-to-OR2G6 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (OR2G6→partner) and Y-score (partner→OR2G6) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LUSC	PI3K-p85 →	-0.158	-2.450	.022	.019	3	2
LUSC	CD49b →	+0.447	+2.468	.001	.011	3	2
LUAD	XRCC1 →	+0.143	+2.584	.028	.011	3	1
LUSC	Acetyl-a-Tubulin-Lys40 →	-0.555	-3.000	.041	.035	3	1
LUSC	mTOR →	-0.250	-2.321	.015	.033	3	1
LUSC	PRAS40_pT246 →	-0.173	-2.986	.019	.035	2	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 19 associations by consensus.

Exploration

OR2G6 survival (RNA) · tumor vs normal (RNA) · all OR2G6 data types